Report overview
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
This report aims to provide a comprehensive presentation of the global market for Anticoagulation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulation Therapy. This report contains market size and forecasts of Anticoagulation Therapy in global, including the following market information:
Global Anticoagulation Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anticoagulation Therapy market was valued at US$ 26630 million in 2022 and is projected to reach US$ 43100 million by 2029, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. Warfarin has a limited therapeutic window that can be strike by factors such as diet and enabling patients on warfarin to monitor their INR regularly. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC?s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.
We surveyed the Anticoagulation Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulation Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulation Therapy Market Segment Percentages, by Type, 2022 (%)
NOACs
Warfarin
Global Anticoagulation Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulation Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
Global Anticoagulation Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anticoagulation Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulation Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anticoagulation Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson?Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticoagulation Therapy, market overview.
Chapter 2: Global Anticoagulation Therapy market size in revenue.
Chapter 3: Detailed analysis of Anticoagulation Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticoagulation Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
